SCHEMBL9375682

SCHEMBL9375682

Cc1ccn2cc(C=Cc3ccc([N+](=O)[O-])cc3)nc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.53
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
ALDH1A1 P00352 3/20 0.53
PKM P14618 1/20 0.53
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
LMNA P02545 2/20 0.43
PTGS2 P35354 6/20 0.42
PTGS1 P23219 2/20 0.42
NFE2L2 Q16236 1/20 0.42
HPGD P15428 1/20 0.42
CYP19A1 P11511 2/20 0.42
APP P05067 1/20 0.40
GAA P10253 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9375681 1.00 MAPT (0.53) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL9377471 0.76 MAPT (0.43) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL9377467 0.76 MAPT (0.43) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL9379486 0.75 CTSV (0.43) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL9380386 0.75 MAPT (0.39) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL9382219 0.72 MAPT (0.55) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL9382222 0.72 MAPT (0.55) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL8934620 0.72 NPC1 (0.70) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL8934587 0.71 LMNA (0.52) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL18529320 0.71 NPC1 (0.67) MAPTNPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0356234-B1 New Benzazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1994-05-11 EP disclosed
US-5047411-A Antiulcer Agents, H2-Receptor Antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-09-10 US disclosed
EP-0356234-A2 New Benzazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-02-28 EP disclosed